Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Tracking every penny for budgeting provides clarity and control over finances. This intro highlights the benefits and sets you up for smarter spending.
26,876 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
New York freezes permits for large data centers for up to 12 months while it writes new environmental and energy stan...
Rising chatter about a Stripe-PayPal tie-up to build on-chain payments rails has fintech investors watching closely. ...
Consensys says a third-party contractor linked to North Korea accessed MetaMask code for roughly a month before acces...
CoreWeave sits at the intersection of explosive AI demand and a looming debt challenge. A multi-billion backlog canno...
A leading AI tool creator predicts a seismic shift in coding careers this year, with many engineers pivoting to produ...
A modest uptick followed an analyst upgrade, but the implications go beyond a single day. This article breaks down wh...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
Thor Industries reports a dramatic EPS surprise for Q2, with revenue rising modestly. Yet cash flow weakness and unev...
Costco reported a sturdy quarterly performance, signaling continued strength in its membership model. The company spo...
Bhutan quietly moved nearly $1 million in bitcoin this week as digital-asset outflows weigh on markets in 2026. The m...
Oracle posted stronger-than-expected cloud results for Q3 FY2026, sending ORCL higher and helping the stock lead tech...